Publication | Closed Access

The combination of luteolin and l-theanine improved Alzheimer disease–like symptoms by potentiating hippocampal insulin signaling and decreasing neuroinflammation and norepinephrine degradation in amyloid-β–infused rats

Neurodegenerative DiseasesAlzheimer's DiseaseAgingAmyloid-β–infused RatsMedicineAlzheimer Disease–like SymptomsNeuropharmacologyDegenerative PathologyNeuroprotectionNeurologyNeuroscienceNeurodegenerationHippocampal InsulinPharmacology